Glucocorticoid Induced osteoporosis is the most common cause of secondary osteoporosis, most common iatrogenic cause of disease
- Previous and current exposure to glucocorticoids (GCs) increases the risk of fracture and bone loss.
- The increase in fracture risk is not fully assessed by bone mineral density (BMD); is also related to alteration in bone quality and falls.
- Prevention or treatment of osteoporosis should be considered in all patients who receive GCs, any dose of steroid increases risk of fractures; but higher the steroid dose greater the risk of bone loss and fractures.
- Number guidelines for GIOP, which remains under-diagnosed and under-treated.
- London Osteoporosis Clinic team are happy to help with management of complex cases.
If you have received or are receiving steroid therapy for any medical condition, please be assessed for the need to have treatment to protect or restore your bones.